ProText Mobility, Inc. (TXTM)
OTCMKTS · Delayed Price · Currency is USD
0.0037
-0.0003 (-7.50%)
Jul 16, 2026, 1:05 PM EST
ProText Mobility Market Cap
ProText Mobility has a market cap or net worth of $33.41 million as of July 17, 2026. Its market cap has decreased by -13.64% in one year.
Market Cap
33.41M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since January 3, 2017, ProText Mobility's market cap has increased from 584.01K to 33.41M, an increase of 5,620.25%. That is a compound annual growth rate of 52.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 35.16M | 17.65% |
| Dec 31, 2025 | 29.89M | 240.00% |
| Dec 31, 2024 | 8.79M | -41.18% |
| Dec 29, 2023 | 14.95M | 19.00% |
| Dec 30, 2022 | 12.56M | 21.42% |
| Dec 31, 2021 | 10.34M | 276.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NDT Pharmaceuticals | 71.78M |
| BioStem Technologies | 67.52M |
| Cell Source | 54.19M |
| Nuo Therapeutics | 47.44M |
| Vicapsys Life Sciences | 47.26M |
| Arch Biopartners | 40.76M |
| Sangamo Therapeutics | 26.93M |
| Provectus Biopharmaceuticals | 26.77M |